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Seborrheic Dermatitis  
Background  
1. Definition  
o Common condition of skin regions rich in sebaceous glands characterized 
by flaking, erythema, itching 
o May present at all ages 
o In infants often presents as "Cradle cap" on the scalp and in adults as a rash 
in the nasolabial folds and brows, chest, axilla, under breasts, around the 
umbilicus or scalp 
 
Pathophysiology  
1. Pathology of disease  
o Etiology unknown but several hypotheses  
 Fungal infection  
 Causal relationship with yeasts Malassezia furfur and 
Malassezia ovalis 
 Also associated with HIV/AIDS 
 Hormone levels  
 Correlated with infancy and re-appearance at puberty 
 Nutritional  
 Mechanism unclear 
 Altered fatty acid pattern  
 Associated with infantile variant 
 Neurogenic factors  
 Higher percentages in those with Parkinsonism, post-CVA, 
epilepsy, CNS trauma, facial nerve palsy, syringomyelia 
2. Incidence, prevalence  
o Men > women 
o Infants < 6 months (usually) 
o Adolescents, young adults; adults 30-60 years 
o 1-3% in immunocompetent adults 
o Underreported in mild cases 
3. Risk factors  
o Unrelated to personal cleanliness 
4. Morbidity / mortality  
o Psychosocial is primary morbidity in most  
 Secondary infection may produce weeping dermatitis/crusting 
 If involves 90% or more of body referred to as erythroderma or 
exfoliative dermatitis 
 Erythroderma Desquamativum (Leiner's disease)  
 Severe seborrheic dermatitis with diarrhea and 
lymphadenopathy in infants  
 Check for immunodeficiencies (SOR:C)
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Diagnostics  
1. History  
o Itching, scaling, burning (active phase) 
o More in winter, early spring; followed by inactive period, in characteristic 
locations  
2. Physical exam  
o Red, flaky greasy appearance in scalp (dandruff), eyebrows, lid margins 
(blepharitis), behind ears, nasolabial folds, pre-sternal, axilla, navel, groin, 
infra-mammary, anogenital; hypopigmentation in blacks; symmetric 
distribution 
o 2 rash types on chest  
 Petaloid  
 Reddish brown, follicular, and peri-follicular papules with 
greasy scales 
 Papules may expand to flower-petal shaped patches 
 Pityriasiform (less common)  
 Generalized macules and patches, common on trunk and 
neck, similar to pityriasis rosea 
o Infantile  
 2nd week - 6 months (or longer)  
 Scalp (cradle cap = pityriasis capitis), face, ears, flexural 
folds 
 Symptoms mild 
 Resolves with time on own in most 
3. Diagnostic testing  
o Usually not required 
o If in doubt, skin scraping/biopsy to rule out tinea infection although often 
responds to topical antifungals anyway 
 
Differential Diagnosis  
1. Scalp  
o Tinea capitis, psoriasis, infected eczema 
2. Face  
o Rosacea, facial chapping, SLE 
3. Body  
o Atopic eczema, psoriasis, tinea versicolor, drug eruptions , candidiasis 
(groin), staph blepharitis 
4. Infants  
o Atopic eczema, scabies, psoriasis, irritant contact dermatitis 
 
Therapeutics  
1. High recurrence rate, goal is most often control, not cure  
o If severe/widespread, assess if diagnosis correct or if patient 
immunocompromised  
2. Infants  
o Will spontaneously resolve in wks-months 
 
Seborrheic Dermatitis Page 3 of 4    10.21.09 
o Overnight soak with baby oil, white petroleum jelly; wash with baby 
shampoo 
o If ineffective, ketoconazole 2% cream once daily  
 Ketoconazole appears to be safe and efficacious for infants with 
cradle cap  
 Other OTC topical antifungals also likely effective. 
o Topical steroids not advised other than possibly briefly for diaper areas 
3. Adults and adolescents  
o Scalp and beard  
 Tx may include topical keratolytics, antifungals and steroidal 
creams/liniments  
 Antifungals (2-3 times/wk for 2-4 weeks)  
 Ketoconazole 2% 
 Clotrimazole 1% 
 Selenium sulfide 1% (Selsun Blue) or 2.5% (Exsel, Sesun)
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 Keratolytics (2-3 times/wk initially then as needed)  
 Coal tar (DHS Tar, Zetar, Ionil T Plus) 
 Salicylic acid 2% cream/gel/lotion/shampoo (Fostex, Stidex) 
 Sulfur 2-3% cream/lotion/shampoo 
 Pyrithione zinc 1% (Dandrex, Zincon, Head & Shoulders) 
and 2% (DHS Zinc, Sebulon)  
 Patient should leave in hair at least 5 mins to ensure these 
agents get deep into scalp 
 Warm mineral oil with combing of crusts also used.  
 Topical steroids/liniments (2-4 wks)  
 Shampoo (fluocinolone, twice weekly) 
 Steroid solutions (fluocinolone, once daily) 
 Lotion (betamethasone valerate, once daily) 
 Cream (desonide, once daily) 
 Effective in treatment of adult seborrheic dermatitis of scalp 
(SOR:C)
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o Face and body  
 Antifungal shampoos (listed above) can be used frequently on 
affected areas 
 Ketoconazole 2% cream, 1-2/day for 4 wks or until clinical clearing  
 Consider mild corticosteroid cream to settle inflammation 
quickly  
 Ketoconazole qD topically with desonide qD for 2 weeks 
may be useful for facial dermatitis 
 Topical calcineurin inhibitors (eg tacrolimus ointment, 
pimecrolimus cream) for face, ears once daily; have fungicidal and 
anti-inflammatory properties  
 Daily use for 1 week necessary before benefits seen 
(SOR:B)
1
  
o Blepharitis  
 Gentle cleansing of eyelid margin twice daily with cotton swab 
dipped in 1/2 cup warm water containing 2-3 drops baby shampoo 
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Follow-Up  
1. F/U if poor response to treatment, worsening symptoms, infection 
2. Refer to specialist  
o Severe, widespread 
o Diagnostic uncertainty 
o No response to treatment 
 
Patient Education 
1. http://familydoctor.org/online/famdocen/home/common/skin/disorders/157.html 
 
Evidence-Based Inquiry 
1. What is the best treatment for cradle cap? 
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